RSA 2011 DAILY SCHEDULE - Research Society on Alcoholism

<strong>RSA</strong> <strong>2011</strong> <strong>DAILY</strong> <strong>SCHEDULE</strong>
TUESDAY, JUNE 28 TUESDAY, JUNE 28
2:00pm - 4:00pm SYMPOSIUM REGENCY VII
RECEPTORS AND ENZYMES: NEW MOLECULAR TARGETS
FOR THE TREATMENT OF ALCOHOL ABUSE DSORDERS
Organizer/Chair: Dorit Ron, E. Gallo Clinic and <strong>Research</strong> Ctr., Dept. of Neurology, Univ. of California, Emeryville, CA 94608
2:00 INTRODUCTION
Antonio Noronha, Div. of Neuroscience and Behavior, NIAAA/NIH, Bethesda, MD 20892
2:10 REVISITING KAPPA-OPIOID RECEPTORS AS A TARGET FOR TREATMENT OF ALCOHOLISM: SOME UNEXPECTED RESULTS
USING THE ANTAGONIST JDTIC
Jesse Schank, NIAAA/NIH, Bethesda, MD 20892
2:35 AMYGDALA PARACAPSULAR CELLS AND BETA-3 ADRENOCEPTORS: NOVEL TARGETS FOR THE TREATMENT OF ALCOHOL
USE DISORDERS
Jeff Weiner, Dept. of Physiology and Pharmacology, Wake Forest Univ., Winston-Salem, NC 27106
3:00 HISTONE DEACETYLASE-2 ISOFORM AND CHROMATIN REMODELING IN THE AMYGDALA: A ROLE IN ANXIETY AND
ALCOHOLISM
Subhash Pandey, Dept. of Psychiatry, Univ. of Illinois, Chicago, IL 60612
3:25 mTOR IS A NEW TARGET FOR THE TREATMENT OF ALCOHOL ABUSE DISORDERS
Sami Ben Hamida, E. Gallo Clinic and <strong>Research</strong> Ctr., Univ. of California, Emeryville, CA 94608
3:50 DISCUSSANT
Antonio Noronha, Div. of Neuroscience and Behavior, NIAAA/NIH, Bethesda, MD 20892
2:00pm - 4:00pm SYMPOSIUM HANOVER FG
***EMERGENT TECHNOLOGIES AND INNOVATIVE APPROACHES
FOR ELUCIDATING GENETIC RISK FOR ALCOHOL DEPENDENCE
Organizer/Chair: Mary-Anne Enoch, Lab. of Neurogenetics, NIAAA/NIH, Bethesda, MD 20892
Chair: David Goldman, Lab. of Neurogenetics, NIAAA/NIH, Bethesda, MD 20892
2:00 INTRODUCTION
Mary-Anne Enoch, Lab. of Neurogenetics, NIAAA/NIH, Bethesda, MD 20892
2:10 WHOLE GENOME SEQUENCING BASED ANALYSIS OF HIPPOCAMPAL GENE EXPRESSION AND DNA METHYLATION IN
ALCOHOL-PREFERRING AND NON-PREFERRING RATS
Zhifeng Zhou, Lab. of Neurogenetics, NIAAA/NIH, Bethesda, MD 20892
2:35 2B OR NOT 2B: A COMMON, POPULATION-SPECIFIC HTR2B STOP CODON LEADING TO IMPULSIVITY AND ALCOHOLISM
David Goldman, Lab. of Neurogenetics, NIAAA/NIH, Bethesda, MD 20892
3:00 STRATEGIES FOR UNDERSTANDING THE GENETIC RISK FOR ALCOHOLISM
Howard Edenberg, Indiana Univ. School of Medicine, Indianapolis, IN 46202
3:25 INTEGRATIVE GENOMICS OF ALCOHOL USE AND ALCOHOL RESPONSE: FINDING CONVERGENT EVIDENCE ACROSS
SPECIES AND EXPERIMENTAL SYSTEMS
Elissa Chesler, The Jackson Laboratory, Bar Harbor, ME 04609
3:50 DISCUSSANT
Robert Hitzemann, Oregon Health and Science Univ., Portland, OR 97239
***Indicates an integrative symposium. We strongly encouraged proposals that bridge different types of research (e.g., preclinical and clinical), to provide the
opportunity for society members with different interests to interact.
36